XML 14 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Assets    
Fixed maturity securities available-for-sale, at fair value (amortized cost of $5,782,649 and $5,559,886 as of September 30, 2024, and December 31, 2023, respectively) $ 5,652,399 $ 5,266,141
Short-term investments, at fair value 1,550 20,219
Total investments 5,653,949 5,286,360
Cash and cash equivalents 673,363 615,683
Accrued investment income 45,954 41,559
Deferred acquisition costs 24,160 25,006
Premiums receivable 48,834 45,070
Other assets 100,723 88,306
Deferred tax asset 50,063 88,489
Total assets 6,597,046 6,190,473
Liabilities:    
Loss reserves 510,401 518,191
Unearned premiums 121,382 149,330
Other liabilities 186,312 145,189
Long-term borrowings 742,706 745,416
Total liabilities 1,560,801 1,558,126
Equity:    
Common stock ($0.01 par value; 600,000 shares authorized; 154,450 shares issued and outstanding as of September 30, 2024, and 159,344 shares issued and outstanding as of December 31, 2023) 1,544 1,593
Additional paid-in capital 2,145,518 2,310,891
Accumulated other comprehensive income (101,984) (230,400)
Retained earnings 2,991,167 2,550,263
Total equity 5,036,245 4,632,347
Total liabilities and equity $ 6,597,046 $ 6,190,473